{"id":17222,"date":"2017-09-14T11:09:27","date_gmt":"2017-09-14T09:09:27","guid":{"rendered":"http:\/\/localhost:8888\/TG180623\/?page_id=17222"},"modified":"2026-07-02T18:09:14","modified_gmt":"2026-07-02T16:09:14","slug":"investisseurs","status":"publish","type":"page","link":"https:\/\/www.transgene.com\/fr\/investisseurs\/","title":{"rendered":"Investisseurs"},"content":{"rendered":"\n<div id=\"tetContainer\" class=\"wp-block-uagb-container uagb-block-ec6f09b8 alignfull uagb-is-root-container\">\n<div class=\"wp-block-columns bgImg-05 eplus-wrapper is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\" id=\"tgTetContainer\">\n<div class=\"wp-block-column eplus-wrapper is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:100%\" id=\"degHaut\">\n<div class=\"wp-block-columns eplus-wrapper is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\" id=\"degbas\">\n<div class=\"wp-block-column eplus-wrapper is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:100%\" id=\"ongletBas\">\n<div class=\"cont1200\">\n<h1>Investisseurs<\/h1>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<div id=\"cont1200\" class=\"wp-block-uagb-container uagb-block-d465b6f3 alignfull uagb-is-root-container\"><div class=\"uagb-container-inner-blocks-wrap\">\n<div class=\"wp-block-columns eplus-DMftm2 eplus-wrapper is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\" id=\"hautInvest\">\n<div class=\"wp-block-column eplus-dQOKBV mamouchkaParent eplus-wrapper is-layout-flow wp-block-column-is-layout-flow\">\n<div id=\"Intro\" class=\"maxWidthTxt\">\u00ab\u00a0<i>Notre priorit\u00e9 est de saisir les occasions et de relever les d\u00e9fis tout en garantissant la transparence et une communication ouverte\u00a0\u00bb <\/i><\/div>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns eplus-wrapper is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\" id=\"downloadsInvestors\">\n<div class=\"wp-block-column mamouchkaParent eplus-wrapper is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<figure class=\"wp-block-image size-large edplus_anim-aoiZqT eplus-wrapper\"><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20260924-Transgene-Investor-Presentation.pdf\"><img decoding=\"async\" src=\"https:\/\/www.transgene.com\/wp-content\/uploads\/Investisseur.png\" alt=\"\"\/><\/a><figcaption class=\"wp-element-caption\">T\u00e9l\u00e9charger le Investor presentation<\/figcaption><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column eplus-wrapper is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<figure class=\"wp-block-image size-large edplus_anim-aoiZqT eplus-wrapper\"><a href=\"..\/..\/wp-content\/uploads\/TRANSGENE_DEU-2025_FR.pdf\"><img decoding=\"async\" src=\"https:\/\/www.transgene.com\/wp-content\/uploads\/DEU2025.png\" alt=\"\"\/><\/a><figcaption class=\"wp-element-caption\">T\u00e9l\u00e9charger le DEU transgene 2024<\/figcaption><\/figure>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns eplus-wrapper is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column eplus-wrapper is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n<\/div>\n\n\n\n<div id=\"contactInvestors\" class=\"cgContactInvestisseurs\">\n<h3 style=\"text-align: center;\"><span style=\"color: #ffffff;\">Contacter les Relations Investisseurs<\/span><\/h3>\n<h4 style=\"text-align: center;\"><a href=\"mailto:investorrelations@transgene.com\">investorrelations@transgene.com <\/a><\/h4>\n<div id=\"bthrlink\" class=\"btrh\" style=\"clear: both; width: 100%; text-align: center; margin: 10px 0px 20px 0px;\"><a href=\"mailto:investorrelations@transgene.com?subject=Contact Investisseur Transgene&amp;body=I have read and understood Transgene's Privacy Policy and I agree to receive updates from Transgene. I understand that I may opt out at any time with the \u00ab unsubscribe link \u00bb at the foot of any email communication from Transgene or I can contact communication@transgene.com to request such opting out.\">Abonnez-vous pour recevoir les communiqu\u00e9s d\u00e8s parution<\/a><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns maxWidthTxt eplus-wrapper is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\" id=\"media\">\n<div class=\"wp-block-column eplus-wrapper is-layout-flow wp-block-column-is-layout-flow\">\n<div class=\"contactTitle\" style=\"background-color: #5698da; color: #eee; border-style: solid; border-width: 0px;\">\n<h3 class=\"advgb-accordion-header-title\" style=\"color: inherit;\">Relations presse fran\u00e7aise<\/h3>\n<\/div>\n<div class=\"contactBody\" style=\"border-style: solid !important; border-width: 0px !important; border-color: undefined !important; border-top: none !important;\">\n<p>&nbsp;<\/p>\n<h4>Citigate Dewe Rogerson &amp; Grayling<\/h4>\n<p style=\"text-align: center;\"><strong>Marie Frocrain\/Olivier Bricaud<\/strong> <br>Phone: +33 (0)6 6 63 03 84 91 <br><strong><a href=\"mailto:transgeneFR@citigatedewerogerson.com\">transgeneFR@citigatedewerogerson.com<\/a><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column eplus-wrapper is-layout-flow wp-block-column-is-layout-flow\">\n<div class=\"contactTitle\" style=\"background-color: #5698da; color: #eee; border-style: solid; border-width: 0px;\">\n<h3 class=\"advgb-accordion-header-title\" style=\"color: inherit;\">Relations presse internationale<\/h3>\n<\/div>\n<div class=\"contactBody\" style=\"border-style: solid !important; border-width: 0px !important; border-color: undefined !important; border-top: none !important;\">\n<p>&nbsp;<\/p>\n<h4>MEDiSTRAVA<\/h4>\n<p style=\"text-align: center;\"><strong>Sylvie Berrebi\/Frazer Hall<\/strong> <br>Phone: + 44 (0) 203 928 6900 <br><strong><a href=\"mailto:transgene@medistrava.com\">transgene@medistrava.com<\/a><\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns eplus-wrapper is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column mamouchkaParent eplus-wrapper is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:100vw\">\n<div class=\"container\">\n    <div class=\"accordion panel-group\">\n        <div class=\"panel panel-default\" style=\"display:none\"><\/div>\n        <div class=\"panel panel-default bgacc1\" id=\"Events\">\n            <div class=\"panel-heading waves-effect accTG acc1\">\n                <a href=\"#\" class=\"accordion-link\">\n                    <h4 class=\"panel-title\">Communiqu\u00e9s de presse<\/h4>\n                    <div class=\"accArrow\">\n                        <i class=\"material-icons accordion-toggle-icon\">arrow_downward<\/i>\n                    <\/div>\n                <\/a>\n            <\/div>\n            <div class=\"content-collapse collapsed\">\n                <div class=\"panel-body\">\n                    \n<div id=\"ongletCP\" class=\"wp-block-uagb-container uagb-layout-grid uagb-block-36c4ca29 alignfull uagb-is-root-container\"><div class=\"uagb-container-inner-blocks-wrap\">\n<p class=\"eplus-wrapper wp-block-paragraph\"><\/p>\n\n\n\n<div id=\"ancre-cp\" class=\" eplus-wrapper\"><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-full wp-image-36965\" style=\"max-width: 50px;margin: 20px 0 0 20px\" src=\"https:\/\/www.transgene.com\/wp-content\/uploads\/scroll.jpg\" alt=\"\" width=\"145\" height=\"143\" \/> <ul class=\"lcp_catlist\" id=\"lcp_instance_0\"><li><a class=\"count\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20261109_Q32026_FR.pdf\" title=\"Transgene poursuit ses programmes cliniques et fait le point sur sa situation financi\u00e8re au troisi\u00e8me trimestre 2026\"><div class=\"catlistdate\">9 novembre 2026<\/div>  <div class=\"catlistTitle\">Transgene poursuit ses programmes cliniques et fait le point sur sa situation financi\u00e8re au troisi\u00e8me trimestre 2026<\/div><\/a><\/li><li><a class=\"count\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20261105_IST_BT001_FR.pdf\" title=\"Premier patient trait\u00e9 dans un essai de Phase 1 \u00e9valuant BT-001 de Transgene et BioInvent dans le cancer du rectum\"><div class=\"catlistdate\">5 novembre 2026<\/div>  <div class=\"catlistTitle\">Premier patient trait\u00e9 dans un essai de Phase 1 \u00e9valuant BT-001 de Transgene et BioInvent dans le cancer du rectum<\/div><\/a><\/li><li><a class=\"count\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20261103_SITCAbstract_FR.pdf\" title=\"Transgene pr\u00e9sentera des donn\u00e9es pr\u00e9cliniques au SITC 2026 sur son virus oncolytique innovant ouvrant la voie \u00e0 une administration syst\u00e9mique\"><div class=\"catlistdate\">3 novembre 2026<\/div>  <div class=\"catlistTitle\">Transgene pr\u00e9sentera des donn\u00e9es pr\u00e9cliniques au SITC 2026 sur son virus oncolytique innovant ouvrant la voie \u00e0 une administration syst\u00e9mique<\/div><\/a><\/li><li><a class=\"count\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20261005_SITC_Title_FR.pdf\" title=\"Transgene pr\u00e9sentera un poster sur les donn\u00e9es pr\u00e9cliniques de son virus oncolytique innovant au SITC 2026\"><div class=\"catlistdate\">5 octobre 2026<\/div>  <div class=\"catlistTitle\">Transgene pr\u00e9sentera un poster sur les donn\u00e9es pr\u00e9cliniques de son virus oncolytique innovant au SITC 2026<\/div><\/a><\/li><li><a class=\"count\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20261001_InvestorAccess_FR.pdf\" title=\"Transgene participera \u00e0 l\u2019Investor Access\"><div class=\"catlistdate\">1<sup>er<\/sup> octobre 2026<\/div>  <div class=\"catlistTitle\">Transgene participera \u00e0 l&rsquo;Investor Access<\/div><\/a><\/li><li><a class=\"count\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20260924_RFS26_FR.pdf\" title=\"Transgene \u00e9tend sa plateforme myvac\u00ae, et s\u2019affirme comme acteur cl\u00e9 dans un domaine en pleine \u00e9mergence des immunoth\u00e9rapies individualis\u00e9es contre le cancer\"><div class=\"catlistdate\">24 septembre 2026<\/div>  <div class=\"catlistTitle\">Transgene \u00e9tend sa plateforme myvac\u00ae, et s&rsquo;affirme comme acteur cl\u00e9 dans un domaine en pleine \u00e9mergence des immunoth\u00e9rapies individualis\u00e9es contre le cancer<\/div><\/a><\/li><li><a class=\"count\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20260908_PBG_TG_FR.pdf\" title=\"Transgene \u00e9tend son partenariat strat\u00e9gique avec ProBioGen par un nouvel accord de licence pour la lign\u00e9e cellulaire AGE1.CR.pIX et publient les r\u00e9sultats de la Phase 1 dans Nature Communications\"><div class=\"catlistdate\">8 septembre 2026<\/div>  <div class=\"catlistTitle\">Transgene \u00e9tend son partenariat strat\u00e9gique avec ProBioGen par un nouvel accord de licence pour la lign\u00e9e cellulaire AGE1.CR.pIX et publient les r\u00e9sultats de la Phase 1 dans Nature Communications<\/div><\/a><\/li><li><a class=\"count\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20260902_TG4050_NatCom_FR.pdf\" title=\"Transgene et NEC annoncent 100 % de survie sans r\u00e9cidive apr\u00e8s 3 ans de suivi avec TG4050 et publient les r\u00e9sultats de la Phase 1 dans Nature Communications\"><div class=\"catlistdate\">2 septembre 2026<\/div>  <div class=\"catlistTitle\">Transgene et NEC annoncent 100 % de survie sans r\u00e9cidive apr\u00e8s 3 ans de suivi avec TG4050 et publient les r\u00e9sultats de la Phase 1 dans Nature Communications<\/div><\/a><\/li><li><a class=\"count\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20260625_TGMVA_data_FR.pdf\" title=\"Transgene pr\u00e9sente des donn\u00e9es pr\u00e9cliniques de son vaccin innovant contre le mpox produit sur lign\u00e9e cellulaire, TG-MVA\"><div class=\"catlistdate\">25 juin 2026<\/div>  <div class=\"catlistTitle\">Transgene pr\u00e9sente des donn\u00e9es pr\u00e9cliniques de son vaccin innovant contre le mpox produit sur lign\u00e9e cellulaire, TG-MVA<\/div><\/a><\/li><li><a class=\"count\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20260622_TG4070_FR.pdf\" title=\"Transgene \u00e9tend sa plateforme myvac\u00aeavec TG4070, un vaccin th\u00e9rapeutique individualis\u00e9 dans le cancer du poumon non \u00e0 petites cellules\"><div class=\"catlistdate\">22 juin 2026<\/div>  <div class=\"catlistTitle\">Transgene \u00e9tend sa plateforme myvac\u00aeavec TG4070, un vaccin th\u00e9rapeutique individualis\u00e9 dans le cancer du poumon non \u00e0 petites cellules<\/div><\/a><\/li><\/ul><\/div>\n\n\n\n<h4 class=\" wp-block-heading eplus-wrapper\"><a class=\"arrow-tgo5\" href=\"..\/press-releases\/\">voir tous les communiqu\u00e9s de presse <br> &nbsp;<\/a><\/h4>\n\n\n\n<p class=\"eplus-wrapper wp-block-paragraph\">&nbsp;<\/p>\n\n\n\n<p class=\"eplus-wrapper wp-block-paragraph\"><\/p>\n<\/div><\/div>\n\n                <\/div>\n            <\/div>\n            <div class=\"panel panel-default bgacc2\" id=\"infoInvest\">\n                <div class=\"panel-heading waves-effect accTG acc2\">\n                    <a href=\"#\" class=\"accordion-link\">\n                        <h4 class=\"panel-title\">\u00c9v\u00e8nements, calendrier &amp; webcasts<\/h4>\n                        <div class=\"accArrow\">\n                            <i class=\"material-icons accordion-toggle-icon\">arrow_downward<\/i>\n                        <\/div>\n                    <\/a>\n                <\/div>\n                <div class=\"content-collapse collapsed\">\n                    <div class=\"panel-body\">\n                        <div>\n                            <div class=\"cartouche\">\n                                <h3>\u00c9v\u00e9nements investisseurs<\/h3>\n                                <ul class=\"lcp_catlist\" id=\"lcp_instance_0\"><li><div class='catlistdate'>22 mai 2026<\/div>  <div class='catlistTitle'>Assembl\u00e9e G\u00e9n\u00e9rale des actionnaires<\/div><\/li><\/ul>\n                            <\/div>\n                            <div class=\"cartouche\">\n                                <h3>Calendrier financier<\/h3>\n                                <ul class=\"lcp_catlist\" id=\"lcp_instance_0\"><li><div class='catlistdate'>9 novembre 2026<\/div>  <div class='catlistTitle'>R\u00e9sultats financiers du troisi\u00e8me trimestre 2026<\/div><\/li><li><div class='catlistdate'>24 septembre 2026<\/div>  <div class='catlistTitle'>R\u00e9sultats semestriels 2026<\/div><\/li><li><div class='catlistdate'>22 mai 2026<\/div>  <div class='catlistTitle'>Assembl\u00e9e G\u00e9n\u00e9rale des actionnaires<\/div><\/li><li><div class='catlistdate'>29 avril 2026<\/div>  <div class='catlistTitle'>R\u00e9sultats financiers du premier trimestre 2026<\/div><\/li><li><div class='catlistdate'>24 mars 2026<\/div>  <div class='catlistTitle'>R\u00e9sultats financiers annuels 2025<\/div><\/li><\/ul>\n                                <p>&nbsp;<\/p>\n                            <\/div>\n                            <div class=\"cartouche\">\n                                <h3>Webcasts<\/h3>\n                                <ul class=\"lcp_catlist\" id=\"lcp_instance_0\"><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/lifescievents.com\/event\/ri20slf0\/\" title=\"Transgene \u00e9tend sa plateforme myvac\u00ae avec TG4070\"><div class='catlistdate'>29 juin 2026<\/div>  <div class='catlistTitle'>Transgene \u00e9tend sa plateforme myvac\u00ae avec TG4070<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/edge.media-server.com\/mmc\/p\/y64mb3pc\" title=\"R\u00e9sultats annuels 2025 et point sur l\u2019activit\u00e9 (en anglais)\"><div class='catlistdate'>24 mars 2026<\/div>  <div class='catlistTitle'>R\u00e9sultats annuels 2025 et point sur l\u2019activit\u00e9 (en anglais)<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/lifescievents.com\/event\/fsp25g74n\/\" title=\"TG4050 : De nouvelles donn\u00e9es d\u2019immunologie (Ph.I) pr\u00e9sent\u00e9es au SITC 2025\"><div class='catlistdate'>14 novembre 2025<\/div>  <div class='catlistTitle'>TG4050 : De nouvelles donn\u00e9es d\u2019immunologie (Ph.I) pr\u00e9sent\u00e9es au SITC 2025<\/div><\/a><\/li><\/ul>\n                                <div class=\"txtAlignRight\">\n                                    <a class=\"cgBefore arrowBlue btnArrow3\" style=\"margin-left: 25px;\" href=\"..\/webcasts\/\"> Voir tous les webcasts<\/a>\n                                <\/div>\n                            <\/div>\n                            <p style=\"margin-top:60px\">&nbsp;<\/p>\n                        <\/div>\n                    <\/div>\n                <\/div>\n            <\/div>\n            <div class=\"panel panel-default bgacc3\" id=\"infoBourse\">\n                <div class=\"panel-heading waves-effect accTG acc3\">\n                    <a href=\"#\" class=\"accordion-link\">\n                        <h4 class=\"panel-title\">Information financi\u00e8re<\/h4>\n                        <div class=\"accArrow\">\n                            <i class=\"material-icons accordion-toggle-icon\">arrow_downward<\/i>\n                        <\/div>\n                    <\/a>\n                <\/div>\n                <div class=\"content-collapse collapsed\">\n                    <div class=\"panel-body\">\n                        <div>\n                            \n<div class=\"container \" id=\"FinancialInformation\">\n    <div class=\"accordion2 panel-group\">\n        <div class=\"panel2 panel-default active\" style=\"display:none\">\n           \n        <\/div>\n     <div style=\"margin:40px\">&nbsp;<\/div>\n         <div id=\"KeyFig\" class=\"panel2 panel-default bgwhite\" style=\"opacity: 1\">\n            <div class=\"panel-heading2 waves-effect creme\">\n                <a href=\"#\" class=\"accordion-link2\" aria-expanded=\"false\">\n                    <h4 class=\"panel-title\">Chiffres cl\u00e9s<\/h4>\n                    <div class=\"accArrow\">\n                        <i class=\"material-icons accordion-toggle-icon\">arrow_downward<\/i>\n                    <\/div>\n                <\/a>\n            <\/div>\n            <div class=\"content-collapse2 collapsed\" style=\"display: none\">\n                <div class=\"panel-body2\">\n                    <p>\n                        \n<div class=\"wp-block-columns eplus-wrapper is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column eplus-wrapper is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:100%\">\n<p><em>En millions d&rsquo;euros sauf pour le nombre d&rsquo;actions et les donn\u00e9es par action<\/em><\/p>\n\n\n\n<figure id=\"tabKeyFig\" class=\"is-style-stripes eplus-s4kGHu eplus-wrapper wp-block-table\"><table><thead><tr><td><\/td><td>\n                    <span style=\"color: #ff9800\">\n                        <br>\n                        <strong>                        2025\n                            <br>\n                        <\/strong>\n                    <\/span>\n<\/td><td>\n<span style=\"color: #ff9800\">\n                        <br>\n                        <strong>                        2024\n                            <br>\n                        <\/strong>\n                    <\/span>\n                <\/td><td>\n                    <span style=\"color: #ff9800\">\n                        <br>\n                        <strong>                        2023\n                            <br>\n                        <\/strong>\n                    <\/span>\n                <\/td><td>\n                    <span style=\"color: #ff9800\">\n                        <br>\n                        <strong>\n                            <span style=\"color: #ff9800\">\n                                <strong>2022<\/strong>\n                            <\/span>\n                        <\/strong>\n                        <br>\n                    <\/span>\n                <\/td><td>\n                    <span style=\"color: #ff9800\">\n                        <br>\n                        <strong>\n                            <span style=\"color: #ff9800\">\n                                <strong>2021<\/strong>\n                            <\/span>\n                        <\/strong>\n                        <br>\n                    <\/span>\n                <\/td><td>\n                    <span style=\"color: #ff9800\">\n                        <br>\n                        <strong>\n                            <span style=\"color: #ff9800\">\n                                <strong>2020<\/strong>\n                            <\/span>\n                        <\/strong>\n                        <br>\n                    <\/span>\n                <\/td><td>\n                    <span style=\"color: #ff9800\">\n                        <br>\n                        <strong>\n                            <span style=\"color: #ff9800\">\n                                <strong>2019<\/strong>\n                            <\/span>\n                        <\/strong>\n                        <br>\n                    <\/span>\n                <\/td><\/tr><\/thead><tbody><tr><td><strong><strong>Produits<\/strong><\/strong> <strong>op\u00e9rationnels<\/strong><\/td><td>7,2<\/td><td>6,4<\/td><td>7,9<\/td><td>10,3<\/td><td>17,4<\/td><td>9,9<\/td><td>13,7<\/td><\/tr><tr><td><strong><strong>D\u00e9penses de R&amp;D<\/strong><\/strong><\/td><td>-33,9<\/td><td>-34,3<\/td><td>-29,6<\/td><td>-32,2<\/td><td>-32,9<\/td><td>-27,3<\/td><td>-31,4<\/td><\/tr><tr><td><strong><strong>rais g\u00e9n\u00e9raux<\/strong><\/strong><\/td><td>-7,3<\/td><td>-7,8<\/td><td>-7,0<\/td><td>-7,9<\/td><td>-7,4<\/td><td>-6,5<\/td><td>-7,1<\/td><\/tr><tr><td><strong><strong>R\u00e9sultat net<\/strong><\/strong><\/td><td>-37,5<\/td><td>-34<\/td><td>-22,3<\/td><td>-32,8<\/td><td>-19,5<\/td><td>-17,2<\/td><td>-18,8<\/td><\/tr><tr><td><strong><strong>Consommation de tr\u00e9sorerie<\/strong><\/strong><\/td><td>-38,2<\/td><td>-27,7<\/td><td>-24,0<\/td><td>-22,8<\/td><td>-10,0<\/td><td>-17,0<\/td><td>-20,5<\/td><\/tr><tr><td><strong><strong>Tr\u00e9sorerie disponible<\/strong><\/strong><\/td><td>111,9<\/td><td>16,7<\/td><td>15,7<\/td><td>26,8<\/td><td>49,6<\/td><td>26,3<\/td><td>43,3<\/td><\/tr><tr><td><strong><strong>R\u00e9sultat net par action (\u20ac) &#8211; de base<\/strong><\/strong><\/td><td>-0,26<\/td><td>-0,29<\/td><td>-0,22<\/td><td>-0,33<\/td><td>-0,21<\/td><td>-0,21<\/td><td>-0,23<\/td><\/tr><tr><td><strong><strong>R\u00e9sultat net par action (\u20ac) &#8211; dilu\u00e9<\/strong><\/strong><\/td><td>-0,26<\/td><td>-0,29<\/td><td>-0,22<\/td><td>-0,33<\/td><td>-0,20<\/td><td>-0,21<\/td><td>-0,23<\/td><\/tr><tr><td><strong><strong>Actions en circulation<\/strong><\/strong><\/td><td>274 186 709<\/td><td>132 293 932<\/td><td>100 852 742<\/td><td>100 204 071<\/td><td>97 771 334<\/td><td>83 841 334<\/td><td>83 265 464<\/td><\/tr><\/tbody><\/table><\/figure>\n<\/div>\n<\/div>\n<div class=\"breakEnd\"><\/div>\n                    <\/p>\n                <\/div>\n            <\/div>\n        <\/div>\n        \n   \n        <div class=\"panel2 panel-default bggris\" style=\"opacity: 1\">\n            <div class=\"panel-heading2 waves-effect gris\">\n                <a href=\"#\" class=\"accordion-link2\" aria-expanded=\"false\">\n                    <h4 class=\"panel-title\">Rapports financiers<\/h4>\n                    <div class=\"accArrow\">\n                        <i class=\"material-icons accordion-toggle-icon\">arrow_downward<\/i>\n                    <\/div>\n                <\/a>\n            <\/div>\n            <div class=\"content-collapse2 collapsed\">\n                <div class=\"panel-body2\">\n                    <div>\n                        \n<table role=\"table\" id=\"idReports\">\n    <thead role=\"rowgroup\">\n        \n        <tr role=\"row\">\n            <th role=\"columnheader\">Ann\u00e9es<\/th>\n            <th role=\"columnheader\" class=\"thQuarter\">1\n                <sup>er<\/sup>\n                <br>trimestre\n            <\/th>\n            <th role=\"columnheader\" class=\"thQuarter\">2\n                <sup>\u00e8me<\/sup>\n                <br>trimestre\n            <\/th>\n            <th role=\"columnheader\" class=\"thQuarter\">3\n                <sup>\u00e8me<\/sup>\n                <br>trimestre\n            <\/th>\n            <th role=\"columnheader\" class=\"thQuarter\">4\n                <sup>\u00e8me<\/sup>\n                <br>trimestre\n            <\/th>\n            <th role=\"columnheader\">Rapports semestriels<\/th>\n            <th role=\"columnheader\">DEU<\/th>\n        <\/tr>\n    <\/thead>\n    <tbody role=\"rowgroup\">\n        <tr role=\"row\">\n            <td role=\"cell\">2026<\/td>\n            <td role=\"cell\">\n                <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20260429_Transgene_T1-Resultats_FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20260924_RFS26_FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>                \n            <\/td>\n            <td role=\"cell\">\n                <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20261109_Q32026_FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n\t\t\t\t\n\t\t\t<\/td>\n            <td role=\"cell\">\n                <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/Transgene_RFS26_FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\"> <\/td>\n        <\/tr>\n        <tr role=\"row\">\n            <td role=\"cell\">2025<\/td>\n            <td role=\"cell\">\n                <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20250424_Transgene_2025_T1_update_FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20250916_Transgene_2025_Resultats-Financiers-Semestriels_FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20251104_Transgene_T3_FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n\t\t\t<a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20260324_Transgene_Resultats_annuels_2025_FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n\t\t\t\t<\/td>\n            <td role=\"cell\">\n                <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/TRANSGENE-RFS-2025_FR.pdf\">\n                    <i class=\"fa icoPdfVert\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\"> <a href=\"..\/..\/wp-content\/uploads\/TRANSGENE_DEU-2025_FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdfVert\" aria-hidden=\"true\">DEU<\/i>\n                <\/a>\n                <a href=\"..\/..\/wp-content\/uploads\/969500PDJW8N0FSGGK69-2025-12-31-1-fr.zip\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"xbrl\" aria-hidden=\"true\"><\/i>\n                    &nbsp;(fr)\n                <\/a>\n                &nbsp;<\/td>\n        <\/tr>\n        <tr role=\"row\">\n            <td role=\"cell\">2024<\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/20240514_Transgene_2024_Q1_update_FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/20240924_Transgene_Results_H1_2024_FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/20241107_Transgene_Q3_2024_FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/20250327_Transgene_Resultats_Annuels_2024_FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/TRANSGENE_RAPPORT-FINANCIER-SEMESTRIEL-2024_FR.pdf\">\n                    <i class=\"fa icoPdfVert\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/DEU-2024-Transgene-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdfVert\" aria-hidden=\"true\">DEU<\/i>\n                <\/a>\n                <a href=\"..\/..\/wp-content\/uploads\/969500PDJW8N0FSGGK69-2024-12-31-1-fr.zip\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"xbrl\" aria-hidden=\"true\"><\/i>\n                    &nbsp;(fr)\n                <\/a>\n                &nbsp;\n            <\/td>\n        <\/tr>\n        <tr role=\"row\">\n            <td role=\"cell\">2023<\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/20230510_Transgene_2023_Point_T1_FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/20230920_Transgene_Results_H1_2023_FR_final.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/20231107_Transgene_T3_2023_FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/20240327-Transgene_Results_FY_2023_FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <span class=\"tdInterim\">\n                    <a href=\"..\/..\/wp-content\/uploads\/230920_RAPPORT-TR-SEMESTRIEL-2023_VF.pdf\">\n                        <i class=\"fa icoPdfVert\">&nbsp;<\/i>\n                    <\/a>\n                <\/span>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/DEU-Transgene-2023-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdfVert\" aria-hidden=\"true\">DEU<\/i>\n                <\/a>\n                <a href=\"..\/..\/wp-content\/uploads\/969500PDJW8N0FSGGK69-2023-12-31-fr.zip\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"xbrl\" aria-hidden=\"true\">&nbsp;(fr)<\/i>\n                <\/a>\n                <a href=\"..\/..\/wp-content\/uploads\/Transgene-Amendement-au-DEU-2023.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdfVert\" aria-hidden=\"true\"><\/i>\n                    Amendment(fr)\n                <\/a>\n            <\/td>\n        <\/tr>\n        <tr role=\"row\">\n            <td role=\"cell\">2022<\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/20220510-Transgene_Q1_Financial_update-FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/20220907_Transgene_Resultats_S1_2022_FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/20221107_Transgene_T3_Resultats_Financiers_FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/20230316_Transgene_2022_Full-Year_Results_FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <span class=\"tdInterim\">\n                    <a href=\"..\/..\/wp-content\/uploads\/Transgene_RAPPORT_SEMESTRIEL_2022-VF.pdf\">\n                        <i class=\"fa icoPdfVert\">&nbsp;<\/i>\n                    <\/a>\n                <\/span>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/Transgene_DEU_2022_FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdfVert\" aria-hidden=\"true\">DEU<\/i>\n                <\/a>\n                <a href=\"..\/..\/wp-content\/uploads\/969500PDJW8N0FSGGK69-2022-12-31-fr.zip\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"xbrl\" aria-hidden=\"true\">&nbsp;(fr)<\/i>\n                <\/a>\n            <\/td>\n        <\/tr>\n        <tr role=\"row\">\n            <td role=\"cell\">2021<\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/20210427-Transgene-T1-Resultats-financiers-FR-4.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/20210922-resultats-H1-2021-FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/20211104-Transgene-T3-Resultats-financiers-FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/20220316-Transgene_2021_Full-Year_Results-FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <span class=\"tdInterim\">\n                    <a href=\"..\/..\/wp-content\/uploads\/RAPPORT-SEMESTRIEL-FR-2021.pdf\">\n                        <i class=\"fa icoPdfVert\">&nbsp;<\/i>\n                    <\/a>\n                <\/span>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/URD-2021-Transgene.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdfVert\" aria-hidden=\"true\">DEU<\/i>\n                <\/a>\n                <a href=\"..\/..\/wp-content\/uploads\/969500PDJW8N0FSGGK69-2021-12-31-fr.zip\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"xbrl\" aria-hidden=\"true\">&nbsp;(fr)<\/i>\n                <\/a>\n            <\/td>\n        <\/tr>\n        <tr role=\"row\">\n            <td role=\"cell\">2020<\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2020\/05\/20200506-TG-FINANCIAL-T1-FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/20200916-Resultats-S1-2020-FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/20201105-Transgene-business-update-T3-FR.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/20210310-Transgene-Resultats-2020.pdf\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <span class=\"tdInterim\">\n                    <a href=\"..\/..\/wp-content\/uploads\/Rapport-semestriel-2020-FR.pdf\">\n                        <i class=\"fa icoPdfVert\">&nbsp;<\/i>\n                    <\/a>\n                <\/span>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/TRANSGENE_URD_2020_FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdfVert\">&nbsp;DEU<\/i>\n                <\/a>\n            <\/td>\n        <\/tr>\n        <tr role=\"row\">\n            <td role=\"cell\">2019<\/td>\n            <td role=\"cell\">\n                <a class=\"fa icoPdf\" href=\"..\/..\/wp-content\/uploads\/2019\/05\/20190513-R\u00e9sultats-T1-2019-VF.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">&nbsp;<\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2019\/09\/20190918-Transgene-Resultats-semestriels2019-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\" ..\/..\/wp-content\/uploads\/2019\/11\/20191114-R\u00e9sultats-T3-2019-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a class=\"fa icoPdf\" href=\"..\/..\/wp-content\/uploads\/2020\/03\/20200311-Resultats-2019-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">&nbsp;<\/a>\n            <\/td>\n            <td role=\"cell\">\n                <span class=\"tdInterim\">\n                    <a href=\"..\/..\/wp-content\/uploads\/2019\/09\/20190918-Rapport-Financier-Semestriel-S1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                        <i class=\"fa icoPdfVert\">&nbsp;<\/i>\n                    <\/a>\n                <\/span>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2020\/04\/TRANSGENE_URD_2019_FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdfVert\">&nbsp;DEU<\/i>\n                <\/a>\n            <\/td>\n        <\/tr>\n        <tr role=\"row\">\n            <td role=\"cell\">2018<\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2018\/06\/20180426-R\u00e9sultats-Q1-2018-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2019\/03\/20180919-Resultats-semestriel-2018-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2019\/03\/20181025-CP-Q3-2018-FR-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2019\/04\/20180320-FY-RESULTS-VF-.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <span class=\"tdInterim\">\n                    <a href=\"..\/..\/wp-content\/uploads\/2019\/03\/Transgene-\u2013-Rapport-financier-semestriel-2018.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                        <i class=\"fa icoPdfVert\">&nbsp;<\/i>\n                    <\/a>\n                <\/span>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2019\/04\/DDR-2018-TG-FR-light.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdfVert\">&nbsp;DEU<\/i>\n                <\/a>\n            <\/td>\n        <\/tr>\n        <tr role=\"row\">\n            <td role=\"cell\">2017<\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2017\/04\/20170425-CP-Q1-2017.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2018\/06\/20170913-CP-Resultats-Financiers-H117-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2018\/06\/171019-CP-Q3-2017-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2018\/06\/170321-R\u00e9sultats-2017-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <span class=\"tdInterim\">\n                    <a href=\"..\/..\/wp-content\/uploads\/2018\/06\/Rapport-financier-semestriel-2017-Transgene.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                        <i class=\"fa icoPdfVert\">&nbsp;<\/i>\n                    <\/a>\n                <\/span>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2018\/06\/Transgene-DDR-2017-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdfVert\">&nbsp;DEU<\/i>\n                <\/a>\n            <\/td>\n        <\/tr>\n        <tr role=\"row\">\n            <td role=\"cell\">2016<\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2016\/04\/20160421-PR-VF-Q1-2016-V4-clean.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2016\/09\/20160905-H1-update-FR-V10.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2016\/10\/20161020-Q3-FINANCIAL-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2017\/03\/20170320-2016-Resultats-annuels-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <span class=\"tdInterim\">\n                    <a href=\"..\/..\/wp-content\/uploads\/2016\/09\/q2-2016-fr.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                        <i class=\"fa icoPdfVert\">&nbsp;<\/i>\n                    <\/a>\n                <\/span>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2017\/04\/doc-ref-2016.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdfVert\">&nbsp;DEU<\/i>\n                <\/a>\n            <\/td>\n        <\/tr>\n        <tr role=\"row\">\n            <td role=\"cell\">2015<\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2015\/04\/20150422-PR-VF-Q1-2015.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2015\/09\/20150910-CP-resultats-semestriels-2015-version-finale.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2015\/10\/20151021-PR-VF-Q3-2015-FINAL.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2016\/03\/20160308-2015-Resultats-annuels-vf-version-FINALE.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <span class=\"tdInterim\">\n                    <a href=\"..\/..\/wp-content\/uploads\/2015\/09\/q2-2015-fr.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                        <i class=\"fa icoPdfVert\">&nbsp;<\/i>\n                    <\/a>\n                <\/span>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2016\/04\/doc-ref-2015-fr.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdfVert\">&nbsp;DEU<\/i>\n                <\/a>\n            <\/td>\n        <\/tr>\n        <tr role=\"row\">\n            <td role=\"cell\">2014<\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2014\/10\/140422-pr_financier-q1-2014-vf.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2014\/09\/08-09-14_fr.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2014\/10\/21-10-14_fr.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2015\/03\/20150324-CP-Resultats-annuels-FINAL.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdf\">&nbsp;<\/i>\n                <\/a>\n            <\/td>\n            <td role=\"cell\">\n                <span class=\"tdInterim\">\n                    <a href=\"..\/..\/wp-content\/uploads\/2014\/12\/q2-2014-fr.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                        <i class=\"fa icoPdfVert\">&nbsp;<\/i>\n                    <\/a>\n                <\/span>\n            <\/td>\n            <td role=\"cell\">\n                <a href=\"..\/..\/wp-content\/uploads\/2015\/04\/doc_ref_2014-fr.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\n                    <i class=\"fa icoPdfVert\">&nbsp;DEU<\/i>\n                <\/a>\n            <\/td>\n        <\/tr>\n    <\/tbody>\n<\/table>\n<div class=\"breakEnd\"><\/div>\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n        <div class=\"panel2 panel-default bgwhite\" style=\"opacity: 1\">\n            <div class=\"panel-heading2 waves-effect creme\">\n                <a href=\"#\" class=\"accordion-link2\" aria-expanded=\"false\">\n                    <h4 class=\"panel-title\">Information r\u00e9glement\u00e9e<\/h4>\n                    <div class=\"accArrow\">\n                        <i class=\"material-icons accordion-toggle-icon\">arrow_downward<\/i>\n                    <\/div>\n                <\/a>\n            <\/div>\n            <div class=\"content-collapse2 collapsed\" style=\"display: none\">\n                <div class=\"panel-body2\">\n                    <p>\n                        \n<div class=\"wp-block-columns eplus-wrapper is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\" id=\"ReglInfo\">\n<div class=\"wp-block-column mamouchkaParent eplus-wrapper is-layout-flow wp-block-column-is-layout-flow\">\n<div style=\"padding: 20px;border: 1px solid #000000;border-radius: 10px\">\n<h3>Transgene annonce le succ\u00e8s de son augmentation de capital.<\/h3>\n<p><em><strong>D\u00e9couvrez les d\u00e9tails de l\u2019op\u00e9ration.<\/strong><\/em><\/p>\n<p>Les pages suivantes contiennent des informations relatives \u00e0 l\u2019augmentation de capital de Transgene. Pour des raisons r\u00e9glementaires, l\u2019acc\u00e8s au contenu de ce site est restreint. En cons\u00e9quence, nous vous prions de remplir les champs ci-dessous pour acc\u00e9der aux pages suivantes.<\/p>\n<p><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/Transgene_CP_Resultats_FR.pdf\">\u279c En savoir plus<\/a><\/p>\n<\/div>\n<div class=\"RubTitle Rub2 ongletRub\">\n<h2>Information mensuelle relative au nombre total de droits de vote et d\u2019actions<\/h2>\n<div class=\"HpNews-container datesVoting\">\n<ul class=\"tgcatlistwrap\">\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/2026-DROITS-DE-VOTE.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">2026<\/a><\/li>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/2025-DROITS-DE-VOTE.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">2025<\/a><\/li>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/2024-DROITS-DE-VOTE.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">2024<\/a><\/li>\n<li><a href=\"..\/wp-content\/uploads\/2023-DROITS-DE-VOTE.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">2023<\/a><\/li>\n<li><a href=\"..\/wp-content\/uploads\/2022-DROITS-DE-VOTE.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">2022<\/a><\/li>\n<li><a href=\"..\/wp-content\/uploads\/2021-DROITS-DE-VOTE.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">2021<\/a><\/li>\n<li><a href=\"..\/wp-content\/uploads\/2020-DROITS-DE-VOTE.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">2020<\/a><\/li>\n<li><a href=\"..\/wp-content\/uploads\/2020\/01\/2019-DROITS-DE-VOTE.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">2019<\/a><\/li>\n<li><a href=\"..\/wp-content\/uploads\/2019\/03\/droits-de-vote-decembre-2018.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">2018<\/a><\/li>\n<li><a href=\"..\/wp-content\/uploads\/2019\/06\/2017-DROITS-DE-VOTE.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">2017<\/a><\/li>\n<li><a href=\"..\/wp-content\/uploads\/2017\/01\/droits-de-vote-decembre-2016.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">2016<\/a><\/li>\n<li><a href=\"..\/wp-content\/uploads\/2016\/01\/droits-de-vote-12.2015.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">2015<\/a><\/li>\n<li><a href=\"..\/wp-content\/uploads\/2015\/01\/droits_de_vote_2014-12.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">2014<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<div class=\"RubTitle Rub2 ongletRub\">\n<h2>Descriptif des programmes de rachat d\u2019actions propres<\/h2>\n<div class=\"HpNews-container\">\n<ul class=\"tgcatlistwrap\">\n<li><a href=\"..\/wp-content\/uploads\/2014\/09\/2016_descriptif_rachat_actions.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Descriptif du programme de rachat d\u2019actions autoris\u00e9 par l\u2019assembl\u00e9e g\u00e9n\u00e9rale mixte des actionnaires du 24 mai 2016<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<div class=\"RubTitle Rub2 ongletRub\">\n<h2>Information relative au contrat de liquidit\u00e9<\/h2>\n<div class=\"HpNews-container\">\n<ul class=\"tgcatlistwrap\">\n<li><a href=\"..\/wp-content\/uploads\/2020\/01\/20200102-CP-Contrat-liquidite-Oddo-FINAL.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Mise en oeuvre du contrat de liquidit\u00e9<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<div class=\"RubTitle Rub2 ongletRub\">\n<h2>Bilan semestriel du contrat de liquidit\u00e9<\/h2>\n<div class=\"HpNews-container\">\n<ul class=\"tgcatlistwrap\">\n<li>2026 : <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20260706_oddo_bilan_semestriel_FR.pdf\">au 30 juin 2026 <\/a> <\/li>\n<li>2025 : <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20250708-bilan_semestriel_H1_2025_FR.pdf\">au 30 juin 2025 ;<\/a> <a href=\"..\/wp-content\/uploads\/20260112_BilanSemestriel_H2_2025_FR\">au 31 d\u00e9cembre 2025<\/a><\/li>\n<li>2024 : <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20240710_bilan_semestriel_H1_2024_FR.pdf\">au 30 juin 2024 ;<\/a> <a href=\"..\/wp-content\/uploads\/20250107_BilanSemestriel_H2_2024_FR.pdf\">au 31 d\u00e9cembre 2024<\/a><\/li>\n<li>2023 : <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20230712_bilan_semestriel_H1_2023_FR.pdf\">au 30 juin 2023<\/a> ; <a href=\"..\/wp-content\/uploads\/20240104_BilanSemestriel_H2_2023_FR.pdf\">au 31 d\u00e9cembre 2023<\/a><\/li>\n<li>2022 : <a href=\"..\/wp-content\/uploads\/20220707_-_bilan_semestriel_H1_2022_FR.pdf\">au 30 juin 2022<\/a> ; <a href=\"..\/wp-content\/uploads\/20230117_BilanSemestriel_H2_2022_FR.pdf\">au 31 d\u00e9cembre 2022<\/a><\/li>\n<li>2021 : <a href=\"..\/wp-content\/uploads\/20210706-bilan-semestriel-H1-2021-FR.pdf\">au 30 juin 2021<\/a> ; <a href=\"..\/wp-content\/uploads\/20220106-BilanSemestriel-H1-2021-FR.pdf\">au 31 d\u00e9cembre 2021<\/a><\/li>\n<li>2020 : <a href=\"..\/wp-content\/uploads\/20200706-bilan-semestriel-H1-2020-FR.pdf\">au 30 juin 2020<\/a> ; <a href=\"..\/wp-content\/uploads\/20210106-CP-Contrat-liquidite-Oddo.pdf\">au 31 d\u00e9cembre 2020<\/a><\/li>\n<li>2019 : <a href=\"..\/wp-content\/uploads\/2019\/07\/20190709-bilan-semestriel-H1-2019-FR.pdf\">au 30 juin 2019<\/a>; <a href=\"..\/wp-content\/uploads\/2020\/01\/20200114-bilan-semestriel-H2-2019-FR.pdf\">au 31 d\u00e9cembre 2019<\/a><\/li>\n<li>2018 : <a href=\"..\/wp-content\/uploads\/2018\/07\/180704-Bilan-semestriel-contrat-liquidit\u00e9-FR.pdf\">au 30 juin 2018<\/a> ; <a href=\"..\/wp-content\/uploads\/2019\/04\/20190107-bilan-semestriel-H2-2018-FR.pdf\">au 31 d\u00e9cembre 2018<\/a><\/li>\n<li>2017 : <a href=\"..\/wp-content\/uploads\/2017\/07\/20170705-bilan-semestriel-H1-2017-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">au 30 juin 2017<\/a> ; <a href=\"..\/wp-content\/uploads\/2018\/06\/Bilan-semestriel-H2-2017-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">au 31 d\u00e9cembre 2017<\/a><\/li>\n<li>2016 : <a href=\"..\/wp-content\/uploads\/2016\/07\/bilan-semestriel-h1-2016-fr.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">au 30 juin 2016<\/a> ; <a href=\"..\/wp-content\/uploads\/2017\/01\/20170104-bilan-semestriel-H2-2016-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">au 31 d\u00e9cembre 2016<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<div class=\"RubTitle Rub2 ongletRub\">\n<h2>Conventions r\u00e9glement\u00e9es<\/h2>\n<div class=\"HpNews-container\">\n<ul class=\"tgcatlistwrap\">\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/Information-sur-la-convention-reglementee-avance-TSGH-Avenant.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">29 juillet 2024<\/a><\/li>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/Information-sur-la-convention-reglementee-Contrat-Prestations-service-072024.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">2 juillet 2024<\/a><\/li>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20230920_Information_convention_reglementee.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">20 septembre 2023<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<div class=\"RubTitle Rub2 ongletRub\">\n<h2>Augmentation de capital<\/h2>\n<div class=\"HpNews-container\">\n<ul class=\"tgcatlistwrap\">\n<li><a href=\"..\/wp-content\/uploads\/2017\/01\/Transgene_Note-doperation.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Note d\u2019op\u00e9ration (octobre-novembre 2016)<\/a><\/li>\n<li><a href=\"http:\/\/finance.transgene.fr\/\" target=\"_blank\" rel=\"noopener noreferrer\">Note d\u2019op\u00e9ration (juin-juillet 2019)<\/a><\/li>\n<li><a href=\"..\/wp-content\/uploads\/Transgene-Note-d-Operation.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Note d\u2019op\u00e9ration (juillet 2024)<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column mamouchkaParent eplus-wrapper is-layout-flow wp-block-column-is-layout-flow\">\n<div class=\"RubTitle Rub2 ongletRub\">\n<h2>Rapport du pr\u00e9sident sur la gouvernance d\u2019entreprise et le contr\u00f4le interne<\/h2>\n<div class=\"HpNews-container\">\n<ul class=\"tgcatlistwrap\">\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/TRANSGENE_DEU-2025_FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Document d\u2019enregistrement universel 2025 (page 59)<\/a><\/li>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/DEU-2024-Transgene-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Document d\u2019enregistrement universel 2024 (page 57)<\/a><\/li>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/DEU-Transgene-2023-FR.pdf \" target=\"_blank\" rel=\"noopener noreferrer\">Document d\u2019enregistrement universel 2023 (page 63)<\/a><\/li>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/Transgene_DEU_2022_FR.pdf \" target=\"_blank\" rel=\"noopener noreferrer\">Document d\u2019enregistrement universel 2022 (page 63)<\/a><\/li>\n<li><a href=\"..\/wp-content\/uploads\/URD-2021-Transgene.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Document d\u2019enregistrement universel 2021 (page 73)<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<div class=\"RubTitle Rub2 ongletRub\">\n<h2>Honoraires des Commissaires aux comptes<\/h2>\n<div class=\"HpNews-container\">\n<ul class=\"tgcatlistwrap\">\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/TRANSGENE_DEU-2025_FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Document d\u2019enregistrement universel 2025 (page 242)<\/a><\/li>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/DEU-2024-Transgene-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Document d\u2019enregistrement universel 2024 (page 234)<\/a><\/li>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/DEU-Transgene-2023-FR.pdf \" target=\"_blank\" rel=\"noopener noreferrer\">Document d\u2019enregistrement universel 2023 (page 246)<\/a><\/li>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/Transgene_DEU_2022_FR.pdf \" target=\"_blank\" rel=\"noopener noreferrer\">Document d\u2019enregistrement universel 2022 (page 242)<\/a><\/li>\n<li><a href=\"..\/wp-content\/uploads\/URD-2021-Transgene.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Document d\u2019enregistrement universel 2021 (page 220)<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<div class=\"RubTitle Rub2 ongletRub\">\n<h2>Documents pr\u00e9paratoires \u00e0 l\u2019assembl\u00e9e g\u00e9n\u00e9rale<\/h2>\n<div class=\"HpNews-container\">\n<ul class=\"tgcatlistwrap\">\n<li>22 mai 2026 : <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/0-2026-AGM-Brochure-VD.pdf\" target=\"_blank\" rel=\"noopener\">Avis de convocation<\/a> \u2013 <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/17805_RESULTATS-DU-SCRUTIN.pdf\" target=\"_blank\" rel=\"noopener\" data-wplink-edit=\"true\">R\u00e9sultats du vote<\/a> \u2013 <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/AG-2026-projet-PV-clean-final.pdf\" target=\"_blank\" rel=\"noopener\">Proc\u00e8s verbal<\/a><\/li>\n<li>15 mai 2025 : <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/3-2025-AGM-Brochure-VD.pdf\" target=\"_blank\" rel=\"noopener\">Avis de convocation<\/a> \u2013 <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/TRANSGENE-2025_Resultats-du-scrutin.pdf\" target=\"_blank\" rel=\"noopener\" data-wplink-edit=\"true\">R\u00e9sultats du vote<\/a> \u2013 <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/PV-AG-15-mai-2025-enregistre-et-signe.pdf\" target=\"_blank\" rel=\"noopener\">Proc\u00e8s verbal<\/a><\/li>\n<li>15 mai 2024 : <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/1-Transgene-Brochure-AG-FR-15Mai2024.pdf\" target=\"_blank\" rel=\"noopener\">Avis de convocation<\/a> \u2013 <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/240515-TRANSGENE-RESULTAT-DE-SCRUTIN.pdf\" target=\"_blank\" rel=\"noopener\" data-wplink-edit=\"true\">R\u00e9sultats du vote<\/a> \u2013 <a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/PV-AG-15-mai-2024-enregistre-et-signe.pdf\" target=\"_blank\" rel=\"noopener\">Proc\u00e8s verbal<\/a><\/li>\n<li>15 mai 2024 : <a href=\"..\/..\/wp-content\/uploads\/3-2025-AGM-Brochure-VD.pdf\" target=\"_blank\" rel=\"noopener\">Avis de convocation<\/a> \u2013 <a href=\"..\/..\/wp-content\/uploads\/TRANSGENE-2025_Resultats-du-scrutin.pdf\" target=\"_blank\" rel=\"noopener\" data-wplink-edit=\"true\">R\u00e9sultats du vote<\/a> \u2013 <a href=\"#\" target=\"_blank\" rel=\"noopener\">Proc\u00e8s verbal<\/a><\/li>\n<li>5 mai 2023 : <a href=\"..\/wp-content\/uploads\/balo-rectificatif-du-12-avril-2023.pdf\" target=\"_blank\" rel=\"noopener\">Avis de convocation<\/a> \u2013 <a href=\"..\/wp-content\/uploads\/Resultat-des-votes_AG-TRANSGENE-05-05-2023.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9sultats du vote<\/a> \u2013 <a href=\"..\/wp-content\/uploads\/PV-AG-5mai2023-enregistre-et-signe.pdf\" target=\"_blank\" rel=\"noopener\">Proc\u00e8s verbal<\/a><\/li>\n<li>25 mai 2022 : <a href=\"..\/wp-content\/uploads\/balo-au-1eravril2022.pdf\" target=\"_blank\" rel=\"noopener\">Avis de convocation<\/a> \u2013 <a href=\"..\/wp-content\/uploads\/Resultats-scrutin.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9sultats du vote<\/a> \u2013 <a href=\"..\/wp-content\/uploads\/PV-AG-25mai2022.pdf\" target=\"_blank\" rel=\"noopener\">Proc\u00e8s verbal<\/a><\/li>\n<li>26 mai 2021 : <a href=\"..\/wp-content\/uploads\/BALO-2020.pdf\" target=\"_blank\" rel=\"noopener\">Avis de convocation<\/a> \u2013 <a href=\"..\/wp-content\/uploads\/Resultats-du-scrutin.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9sultats du vote<\/a> \u2013 <a href=\"..\/wp-content\/uploads\/PV-AG-26mai2021.pdf\" target=\"_blank\" rel=\"noopener\">Proc\u00e8s verbal<\/a><\/li>\n<li>27 mai 2020 :\u00a0 <a href=\"..\/wp-content\/uploads\/2020\/04\/Transgene-BALO-2020.pdf\" target=\"_blank\" rel=\"noopener\">Avis de convocation<\/a> \u2013 <a href=\"..\/wp-content\/uploads\/2020\/05\/R%C3%A9sultat-du-vote-TRANSGENE-27-05-2020.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9sultats du vote<\/a> \u2013 <a href=\"..\/wp-content\/uploads\/PV-AGE-27-05-2020.pdf\" target=\"_blank\" rel=\"noopener\">Proc\u00e8s verbal<\/a><\/li>\n<li>22 mai 2019 : <a href=\"..\/wp-content\/uploads\/2019\/04\/Trangene-Brochure-AG-FR-22-Mai-2019-SGSS.pdf\">Avis de convocation<\/a> \u2013 <a href=\"..\/wp-content\/uploads\/2019\/06\/R\u00e9sultat-du-scrutin-2018.pdf\">R\u00e9sultats du vote<\/a> \u2013 <a href=\"..\/wp-content\/uploads\/2019\/06\/PV-AGEO-22-mai-2019-DEFINITIF-SIGNE.pdf\">Proc\u00e8s verbal<\/a><\/li>\n<li>23 mai 2018 : <a href=\"..\/wp-content\/uploads\/2018\/06\/Transgene-AG2018.pdf\">Avis de convocation<\/a> \u2013 <a href=\"..\/wp-content\/uploads\/2019\/06\/R\u00e9sultat-du-scrutin-2018.pdf\">R\u00e9sultats du vote<\/a> \u2013 <a href=\"..\/wp-content\/uploads\/2018\/06\/ag2018pv_signed.pdf\">Proc\u00e8s verbal<\/a><\/li>\n<li>8 juin 2017 : <a href=\"..\/wp-content\/uploads\/2017\/05\/Transgene-AG-2017.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Avis de convocation<\/a> \u2013 <a href=\"..\/wp-content\/uploads\/2019\/06\/R\u00e9sultats-du-vote-AG-TRANSGENE-08.06.2017.pdf\">R\u00e9sultats du vote<\/a> \u2013 <a href=\"..\/wp-content\/uploads\/2020\/04\/20170608-PV-AG.pdf\">Proc\u00e8s verbal<\/a><\/li>\n<li>24 mai 2016 : <a href=\"..\/wp-content\/uploads\/2016\/05\/ag2016-convocation-fr3.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Avis de convocation<\/a> \u2013 <a href=\"..\/wp-content\/uploads\/2019\/06\/AGM-2016-Resultats-vote.pdf\">R\u00e9sultats du vote<\/a> \u2013 <a href=\"..\/wp-content\/uploads\/2020\/04\/PV-AG-2016-05-24.pdf\">P<\/a> <a href=\"..\/wp-content\/uploads\/2020\/04\/PV-AG-2016-05-24.pdf\">roc\u00e8s verbal<\/a><\/li>\n<li>11 juin 2015 : <a href=\"..\/wp-content\/uploads\/2015\/05\/ag2015-convocation-fr.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Avis de convocation<\/a> \u2013 <a href=\"..\/wp-content\/uploads\/2019\/06\/AGM-2015-Resultats-vote.pdf\">R\u00e9sultats du vote \u2013<\/a> <a href=\"..\/wp-content\/uploads\/2020\/04\/PV-AG-2015-06-11.pdf\">Proc\u00e8s verbal<\/a><\/li>\n<li>18 juin 2014 : <a href=\"..\/wp-content\/uploads\/2014\/12\/ag2014-convocation-fr.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Avis de convocation<\/a> \u2013 <a href=\"..\/wp-content\/uploads\/2019\/06\/RESULTATS-DU-SCRUTIN-2014.pdf\">R\u00e9sultats du vote<\/a>\u2013 <a href=\"..\/wp-content\/uploads\/2020\/04\/PV-AG-2014-06-18.pdf\">Proc\u00e8s verbal<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n<div class=\"breakEnd\"><\/div>\n                    <\/p>\n                <\/div>\n            <\/div>\n        <\/div>\n        \n    <\/div>\n<\/div><div class=\"breakSpace\"><\/div>\n<div class=\"breakEnd\"><\/div>\n\n                        <\/div>\n                    <\/div>\n                <\/div>\n            <\/div>\n            <div class=\"panel panel-default bgacc4\" id=\"Ag\">\n                <div class=\"panel-heading waves-effect accTG acc4\">\n                    <a href=\"#\" class=\"accordion-link\">\n                        <h4 class=\"panel-title\">Information boursi\u00e8re<\/h4>\n                        <div class=\"accArrow\">\n                            <i class=\"material-icons accordion-toggle-icon\">arrow_downward<\/i>\n                        <\/div>\n                    <\/a>\n                <\/div>\n                <div class=\"content-collapse collapsed\">\n                    <div class=\"panel-body\">\n                        <\/p>\n<div class=\"container\" id=\"stockInfoGenAnalysts\">\n<div class=\"accordion2 panel-group\">\n<div class=\"panel2 panel-default active\" style=\"display: none;opacity: 1\"><\/div>\n<div style=\"margin:40px\">&nbsp;<\/div>\n<div class=\"panel2 panel-default bggris\" style=\"opacity: 1\">\n<div class=\"panel-heading2 waves-effect gris\">\n                                    <a href=\"#\" class=\"accordion-link2\" aria-expanded=\"false\"><\/p>\n<h4 class=\"panel-title\">Information g\u00e9n\u00e9rale<\/h4>\n<div class=\"accArrow\"><i class=\"material-icons accordion-toggle-icon\">arrow_downward<\/i><\/div>\n<p>               <\/a>\n           <\/div>\n<div class=\"content-collapse2 collapsed\">\n<div class=\"panel-body2\">\n<div>\n                       <div class=\"wp-block-advgb-columns advgb-columns-wrapper\" id=\"advgb-cols-a87d44cc-d6d5-47eb-9cfc-e8ade67bf1cf\">\n<div class=\"advgb-columns-container\">\n<div class=\"advgb-columns advgb-columns-row advgb-is-mobile advgb-columns-2 layout-12-12 mbl-layout-stacked vgutter-10\">\n<div class=\"wp-block-advgb-column advgb-column advgb-is-half-tablet advgb-is-full-mobile\" id=\"advgb-col-40f88f58-de57-43f6-a9d0-5d1781ccdc8a\">\n<div class=\"advgb-column-inner\" style=\"border-style:none;border-width:1px\">\n<div>\n<h3>Cours de bourse<\/h3>\n<div style=\"text-align: center\"><a title=\"D\u00e9tails sur Euronext\" href=\"https:\/\/www.euronext.com\/fr\/products\/equities\/FR0005175080-XPAR\/quotes\" target=\"_blank\" rel=\"noopener noreferrer\"><\/a><\/div>\n<div class=\"tgtradinglink\"> <a class=\"cgBefore arrowBlue btnArrow3\" href=\"https:\/\/www.euronext.com\/fr\/products\/equities\/FR0005175080-XPAR\/quotes\" target=\"_blank\" rel=\"noopener noreferrer\">Retrouvez en direct le cours de l&rsquo;action Transgene et toutes les informations boursi\u00e8res de Transgene sur Euronext<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"wp-block-advgb-column advgb-column advgb-is-half-tablet advgb-is-full-mobile\" id=\"advgb-col-43d66d96-688a-4140-b902-1f5a009fa221\">\n<div class=\"advgb-column-inner\" style=\"border-style:none;border-width:1px\">\n<h3>G\u00e9n\u00e9ral<\/h3>\n<div>\n<table style=\"width: 100%\" id=\"GenInfo\">\n<tbody>\n<tr>\n<td><strong>March\u00e9<\/strong><\/td>\n<td>Euronext Paris \u2013 Eurolist (compartiment B)<\/td>\n<\/tr>\n<tr>\n<td><strong>Reuters \/ Bloomberg<\/strong><\/td>\n<td>TRNG.PA \/ TNG.FP<\/td>\n<\/tr>\n<tr>\n<td><strong>Code ISIN<\/strong><\/td>\n<td>FR0005175080<\/td>\n<\/tr>\n<tr>\n<td><strong>Nombre de titres<\/strong><\/td>\n<td>274 186 709<\/td>\n<\/tr>\n<tr>\n<td><strong>Cotation<\/strong><\/td>\n<td>26 mars 1998<\/td>\n<\/tr>\n<tr>\n<td><strong>Indice sectoriel Paris<\/strong><\/td>\n<td>Next Biotech<\/td>\n<\/tr>\n<tr>\n<td><strong>Date de cl\u00f4ture<\/strong><\/td>\n<td>31 d\u00e9cembre<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/p>\n<div class=\"breakEnd\"><\/div>\n<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"panel2 panel-default bgwhite\" style=\"opacity: 1\">\n<div class=\"panel-heading2 waves-effect creme\">\n                                    <a href=\"#\" class=\"accordion-link2\" aria-expanded=\"false\"><\/p>\n<h4 class=\"panel-title\">Analystes financiers<\/h4>\n<div class=\"accArrow\"><i class=\"material-icons accordion-toggle-icon\">arrow_downward<\/i><\/div>\n<p>               <\/a>\n           <\/div>\n<div class=\"content-collapse2 collapsed\">\n<div class=\"panel-body\">\n<div id=\"idAnalysts\" class=\"fusion-table table-1 tb-analyste\">\n<table style=\"width: 100%\">\n<thead>\n<tr>\n<th>Soci\u00e9t\u00e9<\/th>\n<th>Analystes<\/th>\n<th>Mail<\/th>\n<th>T\u00e9l\u00e9phone<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>Kempen<\/strong><\/td>\n<td><strong>Chiara Montironi<\/strong><\/td>\n<td><a href=\"mailto:c.montironi@vanlanschotkempen.com\" target=\"_blank\" rel=\"noopener noreferrer\">c.montironi@vanlanschotkempen.com<\/a><\/td>\n<td>+ 31 610552719<\/td>\n<\/tr>\n<tr>\n<td><strong>Intron Health<\/strong><\/td>\n<td><strong>Naresh Chouhan \/ Dominic Rose<\/strong><\/td>\n<td><a href=\"mailto:naresh@intronhealthresearch.com\" target=\"_blank\" rel=\"noopener noreferrer\">naresh@intronhealthresearch.com<\/a><\/td>\n<td>+44 207 375 9143<\/td>\n<\/tr>\n<tr>\n<td><strong>Invest Securities<\/strong><\/td>\n<td><strong>Jamila El Bougrini<\/strong><\/td>\n<td><a href=\"mailto:tvoglimacci@invest-securities.com\" target=\"_blank\" rel=\"noopener noreferrer\">jelbougrini@invest-securities.com<\/a><\/td>\n<td>+33 (0)1 44 88 88 09<\/td>\n<\/tr>\n<tr>\n<td><strong>Oddo BHF<\/strong><\/td>\n<td><strong>Martial Descoutures<\/strong><\/td>\n<td><a href=\"mailto:martial.descoutures@oddo-bhf.com\" target=\"_blank\" rel=\"noopener noreferrer\">martial.descoutures@oddo-bhf.com<\/a><\/td>\n<td>+33 (0)1 44 51 85 00<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div class=\"maxWidth\">\n<p>Les opinions, estimations, projections relatives \u00e0 la Soci\u00e9t\u00e9 \u00e9mises par les analystes financiers sont de leur seule responsabilit\u00e9 et ne refl\u00e8tent pas n\u00e9cessairement celles de la Soci\u00e9t\u00e9 et de sa direction. La Soci\u00e9t\u00e9 n&rsquo;avalise en aucun cas les rapports, conclusions ou recommandations \u00e9mis par les analystes et ne porte aucune responsabilit\u00e9 quant \u00e0 leur exactitude et \u00e0 leur mise \u00e0 jour.<\/p>\n<\/div>\n\n<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"breakEnd\"><\/div><\/p>\n\n                    <\/div>\n                <\/div>\n            <\/div>\n            <div class=\"panel panel-default bgacc5\" id=\"cp\">\n                <div class=\"panel-heading waves-effect accTG acc5\">\n                    <a href=\"#\" class=\"accordion-link\">\n                        <h4 class=\"panel-title\">Assembl\u00e9e g\u00e9n\u00e9rale<\/h4>\n                        <div class=\"accArrow\">\n                            <i class=\"material-icons accordion-toggle-icon\">arrow_downward<\/i>\n                        <\/div>\n                    <\/a>\n                <\/div>\n                <div class=\"content-collapse collapsed\">\n                    <div class=\"panel-body\">\n                        <div class=\"eplus-dN305W wp-block-columns eplus-wrapper is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\" id=\"divAG\">\n<div class=\"eplus-jcGoq8 eplus-wrapper wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<div id=\"titleAG\">\n<p style=\"margin-top: 60px\"><strong>Assembl\u00e9e g\u00e9n\u00e9rale du 22 mai 2026<\/strong><\/p>\n<h2><strong> ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE<\/strong><\/h2>\n<p><strong> <em>Lieu :<\/em> <\/strong> Si\u00e8ge Social de TRANSGENE<\/p>\n<p>400 boulevard Gonthier d&rsquo;Andernach &#8211; Parc d&rsquo;Innovation 67400 ILLKIRCH-GRAFFENSTADEN &#8211; FRANCE<\/p>\n<p><strong><em>Date et heure :<\/em> <\/strong>22 mai 2026 \u00e0 11h00<\/p>\n<div><a href=\"https:\/\/transgene.engagestream.euronext.com\/2026-05-22-ag\/register\" target=\"_blank\" rel=\"noopener\"><u>Lien webcast vers la conf\u00e9rence (en direct et diff\u00e9r\u00e9e)<\/u><\/a><\/div>\n<div>\u00a0<\/div>\n<p><strong><em>Documents<\/em> <\/strong><\/p>\n<ul>\n<li style=\"list-style-type: none\">\n<ul>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/0-2026-AGM-Brochure-VD.pdf\" target=\"_blank\" rel=\"noopener\">Brochure Assembl\u00e9e G\u00e9n\u00e9rale 2026<\/a><\/li>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/1-balo-nr-44-du-13-04-2026.pdf\" target=\"_blank\" rel=\"noopener\">Avis de r\u00e9union Assembl\u00e9e G\u00e9n\u00e9rale 2026 (BALO)<\/a><\/li>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/BALO-4-MAI-2026.pdf\" target=\"_blank\" rel=\"noopener\">Avis de convocation (BALO)<\/a><\/li>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/3-2026-AGM-Lettre-de-convocation-VD-SGGS-1.pdf\" target=\"_blank\" rel=\"noopener\">Lettre de convocation<\/a><\/li>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/4-Expose-sur-les-projets-de-resolutions.pdf\" target=\"_blank\" rel=\"noopener\">Expos\u00e9 sur les projets de r\u00e9solutions<\/a><\/li>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/5-BULLETIN-DE-VOTE.pdf\">Bulletin de vote<\/a><\/li>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/information-relative-au-nombre-total-de-droits-de-vote-b-1.pdf\" target=\"_blank\" rel=\"noopener\">Information relative au nombre total de droits de vote et d\u2019actions composant le capital social (Article R. 225-73-1 du Code du commerce)<\/a><\/li>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/TRANSGENE_DEU-2025_FR.pdf\" target=\"_blank\" rel=\"noopener\">Document d\u2019enregistrement universel 2025<\/a><\/li>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/8-Memo-Article-R225-83.pdf\" target=\"_blank\" rel=\"noopener\">Correspondance article R.225-83<\/a><\/li>\n<li><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/17805_RESULTATS-DU-SCRUTIN.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9sultats du vote<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<div>\u00a0<\/div>\n<\/div>\n<\/div>\n<div class=\"eplus-noVNdl eplus-wrapper wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<p style=\"margin-top:60px\">&nbsp;<\/p>\n<figure class=\"eplus-NoTzlV eplus-wrapper wp-block-image size-large\"><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/0-2026-AGM-Brochure-VD.pdf\"><img decoding=\"async\" src=\"..\/..\/wp-content\/uploads\/ag.png\" alt=\"\" \/><\/a><figcaption class=\"wp-element-caption\"><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/0-2026-AGM-Brochure-VD.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Brochure Assembl\u00e9e G\u00e9n\u00e9rale 2026<\/a><\/figcaption><\/figure>\n<\/div>\n<\/div>\n\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns eplus-wrapper is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column mamouchkaParent entete eplus-wrapper is-layout-flow wp-block-column-is-layout-flow\">\n<div id=\"sloganPiedContainer\">\n<div id=\"sloganPied\">\n<h3 class=\"fusion-responsive-typography-calculated\" style=\"color: white; margin: 0 20px; text-align: center;\" data-fontsize=\"16\" data-lineheight=\"24px\">Pionniers de l\u2019ing\u00e9nierie des g\u00e9nomes viraux, nous avons une ambition : cr\u00e9er des traitements innovants pour lutter contre les cancers.<\/h3>\n<\/div>\n<\/div>\n<p>\u00a0<\/p>\n<\/div>\n<\/div>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Investisseurs \u00ab\u00a0Notre priorit\u00e9 est de saisir les occasions et de relever les d\u00e9fis tout en garantissant la transparence et une communication ouverte\u00a0\u00bb &nbsp; Contacter les Relations Investisseurs investorrelations@transgene.com Abonnez-vous pour recevoir les communiqu\u00e9s d\u00e8s parution Relations presse fran\u00e7aise &nbsp; Citigate Dewe Rogerson &amp; Grayling Marie Frocrain\/Olivier Bricaud Phone: +33 (0)6 6 63 03 84 91&hellip; <a class=\"more-link\" href=\"https:\/\/www.transgene.com\/fr\/investisseurs\/\">Poursuivre la lecture <span class=\"screen-reader-text\">Investisseurs<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":17,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"class_list":["post-17222","page","type-page","status-publish","hentry","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"alcyon","author_link":"https:\/\/www.transgene.com\/fr\/author\/alcyon\/"},"uagb_comment_info":0,"uagb_excerpt":"Investisseurs \u00ab\u00a0Notre priorit\u00e9 est de saisir les occasions et de relever les d\u00e9fis tout en garantissant la transparence et une communication ouverte\u00a0\u00bb &nbsp; Contacter les Relations Investisseurs investorrelations@transgene.com Abonnez-vous pour recevoir les communiqu\u00e9s d\u00e8s parution Relations presse fran\u00e7aise &nbsp; Citigate Dewe Rogerson &amp; Grayling Marie Frocrain\/Olivier Bricaud Phone: +33 (0)6 6 63 03 84 91&hellip;\u2026","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/pages\/17222","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=17222"}],"version-history":[{"count":35,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/pages\/17222\/revisions"}],"predecessor-version":[{"id":41287,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/pages\/17222\/revisions\/41287"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=17222"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}